Michael Narachi
CIK: 0001380022
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RARE
Ultragenyx Pharmaceutical Inc.
Director
Discretionary Trading P&L
Holdings
About NARACHI MICHAEL
NARACHI MICHAEL (SEC CIK 0001380022) files insider reports with the SEC as Director of Ultragenyx Pharmaceutical Inc. (RARE).
Signal8 holds 2 ownership filings by NARACHI MICHAEL, all Form 4s, filed between May 19, 2025 and May 18, 2026. Those filings report 2 transactions, from May 15, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on NARACHI MICHAEL's filings is in NOVATO, CA.
Recent filings by NARACHI MICHAEL
Other insiders filing for Ultragenyx Pharmaceutical Inc. (RARE)
- Horn Howard, Chief Financial Officer
- Huizenga Theodore Alan, SVP, Chief Accounting Officer
- Parschauer Karah Herdman, EVP and Chief Legal Officer
- Sanders Corazon (Corsee) D., Director
- Fust Matthew K, Director
- SULIMAN SHEHNAAZ, Director